Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.

Summary

The bill permits physicians to use stem cell or regenerative medicine treatments that the FDA has not approved, provided the procedure falls within the doctor’s scope of practice and relates to orthopedics, wound care, or pain management. Stem cells must come from FDA‑registered or accredited facilities, meet viability standards, and physicians must include a specific warning notice in any advertising. The measure updates Tennessee’s health‑care statutes to set these requirements.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share